SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-070579
Filing Date
2019-12-06
Accepted
2019-12-06 16:04:54
Documents
3
Period of Report
2019-12-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924642-1_8k.htm 8-K 24390
2 EXHIBIT 99.1 tm1924642d1_ex99-1.htm EX-99.1 21138
3 GRAPHIC tm1924642d1_ex99-1img01.jpg GRAPHIC 59357
  Complete submission text file 0001104659-19-070579.txt   128837
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191273141
SIC: 2834 Pharmaceutical Preparations